136 related articles for article (PubMed ID: 9313773)
1. Inhibition of topoisomerase II by liriodenine.
Woo SH; Reynolds MC; Sun NJ; Cassady JM; Snapka RM
Biochem Pharmacol; 1997 Aug; 54(4):467-73. PubMed ID: 9313773
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase II inhibition by aporphine alkaloids.
Woo SH; Sun NJ; Cassady JM; Snapka RM
Biochem Pharmacol; 1999 May; 57(10):1141-5. PubMed ID: 11230801
[TBL] [Abstract][Full Text] [Related]
3. Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition.
Jensen LH; Renodon-Corniere A; Wessel I; Langer SW; Søkilde B; Carstensen EV; Sehested M; Jensen PB
Mol Pharmacol; 2002 May; 61(5):1235-43. PubMed ID: 11961142
[TBL] [Abstract][Full Text] [Related]
4. DA-125, a new antitumor agent, inhibits topoisomerase II as topoisomerase poison and DNA intercalator simultaneously.
Seo J; Lee HS; Lee M; Kim M; Shin CG
Arch Pharm Res; 2004 Jan; 27(1):77-82. PubMed ID: 14969343
[TBL] [Abstract][Full Text] [Related]
5. Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.
Shin CG; Snapka RM
Biochemistry; 1990 Dec; 29(49):10934-9. PubMed ID: 2176889
[TBL] [Abstract][Full Text] [Related]
6. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
7. The ortho-quinone metabolite of the anticancer drug etoposide (VP-16) is a potent inhibitor of the topoisomerase II/DNA cleavable complex.
Gantchev TG; Hunting DJ
Mol Pharmacol; 1998 Mar; 53(3):422-8. PubMed ID: 9495807
[TBL] [Abstract][Full Text] [Related]
8. The homocamptothecin, BN 80927, is a potent topoisomerase I poison and topoisomerase II catalytic inhibitor.
Demarquay D; Coulomb H; Huchet M; Lesueur-Ginot L; Camara J; Lavergne O; Bigg D
Ann N Y Acad Sci; 2000; 922():301-2. PubMed ID: 11193906
[No Abstract] [Full Text] [Related]
9. Liriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progression.
Nordin N; Majid NA; Hashim NM; Rahman MA; Hassan Z; Ali HM
Drug Des Devel Ther; 2015; 9():1437-48. PubMed ID: 25792804
[TBL] [Abstract][Full Text] [Related]
10. Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288).
Lothstein L; Suttle DP; Roaten JB; Koseki Y; Israel M; Sweatman TW
Biochem Pharmacol; 2000 Dec; 60(11):1621-8. PubMed ID: 11077044
[TBL] [Abstract][Full Text] [Related]
11. Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors.
Permana PA; Snapka RM; Shen LL; Chu DT; Clement JJ; Plattner JJ
Biochemistry; 1994 Sep; 33(37):11333-9. PubMed ID: 7727384
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial and cytotoxic compounds from the bark of Cananga odorata.
Rahman MM; Lopa SS; Sadik G; Harun-Or-Rashid ; Islam R; Khondkar P; Alam AH; Rashid MA
Fitoterapia; 2005 Dec; 76(7-8):758-61. PubMed ID: 16242266
[TBL] [Abstract][Full Text] [Related]
13. Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation of p53 expression.
Hsieh TJ; Liu TZ; Chern CL; Tsao DA; Lu FJ; Syu YH; Hsieh PY; Hu HS; Chang TT; Chen CH
Food Chem Toxicol; 2005 Jul; 43(7):1117-26. PubMed ID: 15833387
[TBL] [Abstract][Full Text] [Related]
14. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
Perrin D; van Hille B; Barret JM; Kruczynski A; Etiévant C; Imbert T; Hill BT
Biochem Pharmacol; 2000 Apr; 59(7):807-19. PubMed ID: 10718339
[TBL] [Abstract][Full Text] [Related]
15. Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro.
Ishimi Y; Ishida R; Andoh T
Mol Cell Biol; 1992 Sep; 12(9):4007-14. PubMed ID: 1324412
[TBL] [Abstract][Full Text] [Related]
16. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
Yang L; Rowe TC; Liu LF
Cancer Res; 1985 Nov; 45(11 Pt 2):5872-6. PubMed ID: 2996763
[TBL] [Abstract][Full Text] [Related]
17. Tirapazamine: a hypoxia-activated topoisomerase II poison.
Peters KB; Brown JM
Cancer Res; 2002 Sep; 62(18):5248-53. PubMed ID: 12234992
[TBL] [Abstract][Full Text] [Related]
18. Etoposide sensitivity of radioresistant human glioma cell lines.
Beauchesne P; Bertrand S; N'guyen MJ; Christianson T; Dore JF; Mornex F; Bonner JA
Cancer Chemother Pharmacol; 1998; 41(2):93-7. PubMed ID: 9443620
[TBL] [Abstract][Full Text] [Related]
19. Effects of ICRF-193, a catalytic inhibitor of DNA topoisomerase II, on sister chromatid exchange.
Hamatake M; Andoh T; Ishida R
Anticancer Drugs; 1997 Jul; 8(6):637-42. PubMed ID: 9300580
[TBL] [Abstract][Full Text] [Related]
20. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
